Institutional Ownership Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS). We have compiled data on the 102 institutions that hold shares in the stock, with a total of 38.1 Million shares, which have been reported (via 13F filing form) to have a value of $172 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
6,943,654
shares
|
$29.6 Million
0.98% of portfolio
|
Q3 2021
Reduced 13.78%
|
|
|
Samlyn Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
6,667,105
shares
|
$28.4 Million
0.56% of portfolio
|
Q4 2024
Added 47.17%
|
|
|
Adams Street Partners LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,275,616
shares
|
$14 Million
18.22% of portfolio
|
Q1 2018
Added 7.01%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
3,030,011
shares
|
$12.9 Million
0.04% of portfolio
|
Q4 2024
Reduced 45.53%
|
|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,679,479
shares
|
$11.4 Million
0.23% of portfolio
|
Q4 2024
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,454,596
shares
|
$10.5 Million
0.0% of portfolio
|
Q4 2024
Added 1.4%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Feb 13, 2025 Q4 2024 |
2,234,566
shares
|
$9.52 Million
2.27% of portfolio
|
Q4 2024
Added 49.24%
|
|
|
Foresite Capital Management Vi LLC
Larkspur, CA |
Feb 14, 2025 Q4 2024 |
1,581,233
shares
|
$6.74 Million
3.77% of portfolio
|
Q4 2024
New holding
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
1,015,083
shares
|
$4.32 Million
0.0% of portfolio
|
Q4 2024
Added 363.59%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$4.26 Million
0.13% of portfolio
|
Q4 2024
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
584,546
shares
|
$2.49 Million
0.0% of portfolio
|
Q4 2024
Added 55.41%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
566,863
shares
|
$2.41 Million
0.0% of portfolio
|
Q4 2024
Added 0.68%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
562,024
shares
|
$2.39 Million
0.0% of portfolio
|
Q2 2024
Added 7.47%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Feb 14, 2025 Q4 2024 |
500,491
shares
|
$2.13 Million
0.54% of portfolio
|
Q4 2024
New holding
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
500,000
shares
|
$2.13 Million
0.99% of portfolio
|
Q3 2024
New holding
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
450,050
shares
|
$1.92 Million
0.0% of portfolio
|
Q4 2024
Added 253.45%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
397,364
shares
|
$1.69 Million
0.0% of portfolio
|
Q4 2024
Added 1.04%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
390,688
shares
|
$1.66 Million
0.0% of portfolio
|
Q4 2024
Added 1.06%
|
|
|
Telemetry Investments, L.L.C.
New York, NY |
Feb 14, 2023 Q4 2022 |
390,000
shares
|
$1.66 Million
0.52% of portfolio
|
Q4 2022
Reduced 25.29%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
205,538
shares
|
$875,591
0.0% of portfolio
|
Q4 2024
Added 15.31%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
154,901
shares
|
$659,878
0.0% of portfolio
|
Q4 2024
Reduced 50.24%
|
|
|
Simplex Trading, LLC
|
Feb 11, 2025 Q4 2024 |
139,933
shares
|
$596,114
0.02% of portfolio
|
Q4 2024
Added 2367.95%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
129,076
shares
|
$549,863
0.0% of portfolio
|
Q4 2024
Reduced 61.05%
|
|
|
Entry Point Capital, LLC
New York, NY |
Feb 11, 2025 Q4 2024 |
116,645
shares
|
$496,907
0.27% of portfolio
|
Q4 2024
New holding
|
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
114,952
shares
|
$489,695
0.0% of portfolio
|
Q4 2024
Added 128.89%
|